Vineet Laboratories Ltd
Vineet Laboratories Ltd (VINEETLAB) last traded at ₹39.1, a market capitalisation of ₹75.1 crore. Over the past 52 weeks the stock has ranged between ₹27 and ₹43.8. Vineet Laboratories Ltd last reported results for the quarter ended Dec 2025, with sales of ₹15.65 crore and net profit of ₹0.85 crore. Figures are as of 25 Aug 2026 and are not real time.
Vineet Laboratories Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Vineet Laboratories Ltd quarterly results
In the quarter ended Dec 2025, sales were ₹15.65 cr, down 13.5% from ₹18.1 cr a year earlier. Net profit turned positive at ₹0.85 cr.
| ₹ crore | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 37.05 | 23.86 | 18.96 | 18.1 | 14.08 | 7.44 | 17.42 | 15.65 |
| Expenses | 33.63 | 24.65 | 19.27 | 22.23 | 25.12 | 7.13 | 14.24 | 13.17 |
| Operating profit | 3.42 | -0.79 | -0.31 | -4.13 | -11.04 | 0.31 | 3.18 | 2.48 |
| OPM % | 9.23% | -3.31% | -1.64% | -22.82% | -78.41% | 4.17% | 18.25% | 15.85% |
| Other income | 0.41 | 0.37 | 0.2 | 0.03 | 1.38 | 0.02 | 0.01 | 0.05 |
| Interest | 1.72 | 1.14 | 0.99 | 0.95 | 0.9 | 0.61 | 2.19 | 1.09 |
| Depreciation | 0.67 | 0.61 | 0.62 | 0.62 | 0.66 | 0.63 | 0.63 | 0.63 |
| Profit before tax | 1.44 | -2.17 | -1.72 | -5.67 | -11.22 | -0.91 | 0.37 | 0.81 |
| Tax % | -34.03% | -1.84% | 6.98% | 0.53% | -6.24% | -4.40% | -8.11% | -3.70% |
| Net profit | 1.92 | -2.13 | -1.83 | -5.71 | -10.53 | -0.87 | 0.4 | 0.85 |
| EPS (₹) | 1.00 | -1.11 | -0.95 | -2.97 | -5.48 | -0.45 | 0.21 | 0.44 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Vineet Laboratories Ltd annual results
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 0 | 243 | 191 | 212 | 151 | 75 | 55 |
| Operating profit | -0 | 8 | 13 | 8 | 7 | -16 | -5 |
| OPM % | — | 3.4% | 7% | 3.6% | 4.8% | -22% | -9% |
| Net profit | -0 | 2 | 7 | 1 | 1 | -20 | -10 |
| EPS (₹) | -0.11 | 0.93 | 3.46 | 0.65 | 0.54 | -10.52 | -5.28 |
TTM is the trailing twelve months to the most recent quarter.
Vineet Laboratories Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- -27%
- TTM
- -44%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -31%
- 10 Years
- %
- 5 Years
- -12%
- 3 Years
- -4%
- 1 Year
- 28%
- 10 Years
- %
- 5 Years
- -9%
- 3 Years
- -22%
- Last Year
- -89%
Vineet Laboratories Ltd shareholding pattern
Promoters held 5.98% at Jun 2026, down from 29.26% at Jun 2025. FIIs 0.50%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 36.07% | 35.85% | 35.85% | 29.26% | 15.89% | 12.46% | 5.98% | 5.98% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.36% | 0.50% |
| Public | 63.93% | 64.15% | 64.15% | 70.74% | 84.11% | 87.54% | 93.67% | 93.52% |
| No. of shareholders | 10,300 | 10,058 | 10,025 | 9,988 | 9,682 | 10,003 | 9,929 | 9,901 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Vineet Laboratories Ltd corporate filings
- The Board of Directors of the company in its meeting held today i.e., on August 25, 2026 has: Approved the Audited Standalone Financial Results of the Company for the fourth quarter and ....Board Meetinghigh impact
Cruxal's analysis: Vineet Laboratories Limited has reported a financial turnaround for the fiscal year ended…
Read the full analysis - Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2026 ,inter alia, to consider and approve the Audited Standalone ....Board Meetinglow impact
Cruxal's analysis: Vineet Laboratories Limited has issued a formal intimation regarding a Board of Directors…
Read the full analysis - Please find the attached Monitoring Agency Report issued by CRISIL rating Limited for quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Vineet Laboratories has filed the Monitoring Agency Report issued by CRISIL Ratings…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Vineet Laboratories Ltd
Cruxal reads every Vineet Laboratories Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.